← Back to headlines
Eli Lilly Announces New Late-Stage Weight Loss Trial Results
Eli Lilly (LLY) has released new results from its late-stage clinical trials for a weight loss treatment, potentially impacting the market for obesity drugs.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
